These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Neurobiology of attention deficit/hyperactivity disorder]. Purper-Ouakil D; Lepagnol-Bestel AM; Grosbellet E; Gorwood P; Simonneau M Med Sci (Paris); 2010 May; 26(5):487-96. PubMed ID: 20510147 [TBL] [Abstract][Full Text] [Related]
3. Neurobiology of animal models of attention-deficit hyperactivity disorder. Russell VA J Neurosci Methods; 2007 Apr; 161(2):185-98. PubMed ID: 17275916 [TBL] [Abstract][Full Text] [Related]
4. Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder? Potter AS; Newhouse PA; Bucci DJ Behav Brain Res; 2006 Dec; 175(2):201-11. PubMed ID: 17081628 [TBL] [Abstract][Full Text] [Related]
9. [ADHD and attachment processes: are they related?]. Franc N; Maury M; Purper-Ouakil D Encephale; 2009 Jun; 35(3):256-61. PubMed ID: 19540412 [TBL] [Abstract][Full Text] [Related]
10. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. van der Kooij MA; Glennon JC Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796 [TBL] [Abstract][Full Text] [Related]
11. Pozanicline for the treatment of attention-deficit/hyperactivity disorder. Childress A; Sallee FR Expert Opin Investig Drugs; 2014 Nov; 23(11):1585-93. PubMed ID: 25196198 [TBL] [Abstract][Full Text] [Related]
13. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Lerman C; Audrain J; Tercyak K; Hawk LW; Bush A; Crystal-Mansour S; Rose C; Niaura R; Epstein LH Nicotine Tob Res; 2001 Nov; 3(4):353-9. PubMed ID: 11694203 [TBL] [Abstract][Full Text] [Related]
14. [How does maternal alcohol consumption during pregnancy affect the development of attention deficit/hyperactivity syndrome in the child]. Burger PH; Goecke TW; Fasching PA; Moll G; Heinrich H; Beckmann MW; Kornhuber J Fortschr Neurol Psychiatr; 2011 Sep; 79(9):500-6. PubMed ID: 21739408 [TBL] [Abstract][Full Text] [Related]
15. Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to date. Potter AS; Schaubhut G; Shipman M CNS Drugs; 2014 Dec; 28(12):1103-13. PubMed ID: 25349138 [TBL] [Abstract][Full Text] [Related]
16. [Characteristics of attention in children with attention deficit hyperactivity disorder (an analytical review)]. Krupskaia EV; Machinskaia RI Zh Vyssh Nerv Deiat Im I P Pavlova; 2006; 56(6):731-41. PubMed ID: 17285768 [TBL] [Abstract][Full Text] [Related]
17. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433 [TBL] [Abstract][Full Text] [Related]
18. Rodent models of attention-deficit/hyperactivity disorder. Sagvolden T; Russell VA; Aase H; Johansen EB; Farshbaf M Biol Psychiatry; 2005 Jun; 57(11):1239-47. PubMed ID: 15949994 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder. Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704 [TBL] [Abstract][Full Text] [Related]
20. The interference of local over global information processing in children with attention deficit hyperactivity disorder of the inattentive type. Song Y; Hakoda Y Brain Dev; 2012 Apr; 34(4):308-17. PubMed ID: 21862271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]